Press Room

Juno is committed to sharing the latest news and information about our company, our progress, and our innovative approaches to the treatment of cancer and other serious diseases.

Juno on Twitter
Follow us on Twitter CTA Icon
Pipeline Progress
Track the progress of our development programs and trials.
Visit our pipeline page CTA Icon

Media Asset Requests

To access authorized graphics, photos and other corporate information, please submit a media request form.
Media Asset Request

For Press Inquiries and Interviews

Please contact us at media@junotherapeutics.com